Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 660 clinical trials
Brugada Ablation of VF Substrate Ongoing MultiCenter Registry

Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term outcomes of CA in BrS ablation are lacking.

brugada syndrome
cardiac ablation
  • 0 views
  • 19 Feb, 2024
The Role of MicroRNA in the Diagnosis Prognosis and Response to Treatment in Pancreatic Cancer

Aberrant miRNA production has been linked to a wide range of human cancers and shown to play important roles in their genesis and growth. These miRNA can be detected in the blood and tumors of patients with cancer.

adenocarcinoma
measurable disease
adjuvant therapy
metastasis
inoperable disease
  • 0 views
  • 19 Feb, 2024
Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV

Prostate cancer (PCa) is a high incidence tumor of elderly men. In recent years, its incidence has rapidly increased in China. Serological examination of prostate-specific antigen (PSA) is particularly important in the early diagnosis of PCa, but its specificity is lower in gray areas with PSA between 4-10 ng / …

transperineal biopsy
prostate health index
transrectal ultrasound
cancer diagnosis
digital rectal examination
  • 0 views
  • 19 Feb, 2024
Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

EXALT-2 is a prospective, randomized, three arm study for treatment decision guided either by either comprehensive genomic profiling, next generation drug screening or physician's choice

basal cell carcinoma of the skin
melanoma of the skin
cancer
  • 0 views
  • 19 Feb, 2024
Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old on an Outpatient Basis

Delayed treatment causes a decrease in survival and quality of life. Cancer can be discovered suddenly: for example, occlusion with peritonitis in case of a stenosing colonic tumor, leading to urgent management.

early diagnosis
early detection
cancer
cancer care
advanced cancer
  • 0 views
  • 19 Feb, 2024
Hyperlactatemia During and After Tumorcraniotomy

This study aims to investigate the association between hyperlactatemia and neurological disability, length-of-stay and mortality in patients who undergo tumorcraniotomy. The risk factors that induce lactat accumulation will also be explored.

hyperlactatemia
craniotomy
  • 0 views
  • 19 Feb, 2024
A Prospective Single-Center Evaluation of SureForm Staplers in Robotic-assisted Colorectal Procedures

The primary objective of this study is to evaluate the performance of SureForm Staplers (60 and 45) for transection and/or creation of anastomosis during robotic-assisted colorectal procedures.

  • 0 views
  • 19 Feb, 2024
Marker Driven Selection of Patients for Prostate Biopsy and Management

The purpose of this research study is to determine if the interpretation of multiparametric MRI (mpMRI) with an algorithm called habitat risk score (HRS) in combination with a panel of blood biomarkers is more effective at detecting prostate cancer than standard of care interpretation of mpMRI with the Prostate Imaging …

testosterone
digital rectal exam
multiparametric magnetic resonance imaging
tumor markers
digital rectal examination
  • 0 views
  • 19 Feb, 2024
Health and Employment After Gastro Intestinal Surgery - HEAGIS2

The principal aim of this study is to create a validated and replicable intervention model for supporting patients who undergone surgery for esophageal and gastro intestinal cancer.

intestinal cancer
metastasis
cancer diagnosis
treatment guidelines
curative surgery
  • 0 views
  • 19 Feb, 2024
Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800 an Inhibitor of the Heat Shock Protein HSP90

NVP-BEP800, a new HSP90 inhibitor, has particularly interesting therapeutic potential and represents hope in cancer pathologies. While it is currently being tested for solid cancers, no preclinical study has yet demonstrated its effectiveness in acute lymphoblastique leukemia (ALL).

  • 0 views
  • 19 Feb, 2024